Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial RF Anton, SS O’Malley, DA Ciraulo, RA Cisler, D Couper, DM Donovan, ... Jama 295 (17), 2003-2017, 2006 | 2252 | 2006 |
Development and validation of the biphasic alcohol effects scale CS Martin, M Earleywine, RE Musty, MW Perrine, RM Swift Alcoholism: Clinical and Experimental Research 17 (1), 140-146, 1993 | 798 | 1993 |
Topiramate for treating alcohol dependence: a randomized controlled trial BA Johnson, N Rosenthal, JA Capece, F Wiegand, L Mao, K Beyers, ... Jama 298 (14), 1641-1651, 2007 | 646 | 2007 |
An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and … RF Anton, G Oroszi, S O’Malley, D Couper, R Swift, H Pettinati, ... Archives of general psychiatry 65 (2), 135-144, 2008 | 541 | 2008 |
Trial of prazosin for post-traumatic stress disorder in military veterans MA Raskind, ER Peskind, B Chow, C Harris, A Davis-Karim, HA Holmes, ... New England Journal of Medicine 378 (6), 507-517, 2018 | 396 | 2018 |
Alcohol hangover: mechanisms and mediators R Swift, D Davidson Alcohol health and research world 22 (1), 54, 1998 | 394 | 1998 |
Drug therapy for alcohol dependence RM Swift Treatment of Substance Use Disorders, 35-54, 2013 | 390 | 2013 |
Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. J MacKillop, R Miranda Jr, PM Monti, LA Ray, JG Murphy, DJ Rohsenow, ... Journal of abnormal psychology 119 (1), 106, 2010 | 353 | 2010 |
Naltrexone-induced alterations in human ethanol intoxication. RM Swift, W Whelihan, O Kuznetsov, G Buongiorno, H Hsuing The American journal of psychiatry 151 (10), 1463-1467, 1994 | 336 | 1994 |
Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1‐year outcomes PM Monti, DJ Rohsenow, RM Swift, SB Gulliver, SM Colby, TI Mueller, ... Alcoholism: Clinical and Experimental Research 25 (11), 1634-1647, 2001 | 317 | 2001 |
Typologies of alcohol dependence. From Jellinek to genetics and beyond L Leggio, GA Kenna, M Fenton, E Bonenfant, RM Swift Neuropsychology review 19, 115-129, 2009 | 264 | 2009 |
Direct measurement of alcohol and its metabolites R Swift Addiction 98, 73-80, 2003 | 260 | 2003 |
Naltrexone's effect on cue‐elicited craving among alcoholics in treatment PM Monti, DJ Rohsenow, KE Hutchison, RM Swift, TI Mueller, SM Colby, ... Alcoholism: Clinical and Experimental Research 23 (8), 1386-1394, 1999 | 249 | 1999 |
The DRD4 VNTR polymorphism moderates craving after alcohol consumption. KE Hutchinson, J McGeary, A Smolen, A Bryan, RM Swift Health Psychology 21 (2), 139, 2002 | 219 | 2002 |
Morphine and endorphins modulate dopamine turnover in rat median eminence. SN Deyo, RM Swift, RJ Miller Proceedings of the National Academy of Sciences 76 (6), 3006-3009, 1979 | 205 | 1979 |
Relief of intractable pruritus with naloxone JE Bernstein, R Swift Archives of Dermatology 115 (11), 1366-1367, 1979 | 204 | 1979 |
Effects of naltrexone on alcohol self‐administration in heavy drinkers D Davidson, T Palfai, C Bird, R Swift Alcoholism: Clinical and Experimental Research 23 (2), 195-203, 1999 | 198 | 1999 |
Research to practice: adoption of naltrexone in alcoholism treatment CP Thomas, SS Wallack, S Lee, D McCarty, R Swift Journal of Substance Abuse Treatment 24 (1), 1-11, 2003 | 183 | 2003 |
Contingency management for alcohol use reduction: a pilot study using a transdermal alcohol sensor NP Barnett, J Tidey, JG Murphy, R Swift, SM Colby Drug and alcohol dependence 118 (2-3), 391-399, 2011 | 179 | 2011 |
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy GA Kenna, N Roder-Hanna, L Leggio, WH Zywiak, J Clifford, S Edwards, ... Pharmacogenomics and personalized medicine, 19-35, 2012 | 177 | 2012 |